Vermont has the second lowest state fatality rate in the US (148.3 per 100K; Hawaii 113.6/100K). Mississippi (465.9/100K) and ...

In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.

NanoViricides, Inc. is a publicly traded clinical-stage company focused on creating special purpose nanomaterials for antiviral therapy. The company's innovative nanoviricide class of drug candidates ...

Scientists at the University of Maryland conducted a systematic review of scientific literature from 2004 to 2024 to assess ...

Cambodia's health ministry today announced another human H5N1 avian flu case of the year, involving a 5-year-old boy from ...

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

Researchers have measured blood virus levels in clade Ia mpox patients during early infection and developed a new approach to help predict the severity of their symptoms.

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

Continuing to vaccinate for mpox through a routine targeted program for gay and bisexual men delivered by sexual health ...

The World Health Organization (WHO) has renewed its declaration that Mpox (formerly monkeypox) remains a Public Health Emergency of International Concern (PHEIC). WHO Director-General Dr. Tedros ...

Vaccination and pre-departure education among Nepali travellers can prevent outbreaks.

An analysis of mpox virus genomes from individuals infected between 2018 and 2023 has provided insights into how the virus ...